Welcome to Coulter Partners Global (English)

27 July 2021

Top hires for VC & PE portfolio companies Q2-2021

Search Highlights

Recent top global hires for Venture Capital and Private Equity backed companies, covering a broad range of disciplines and sectors across Life Sciences, Health, and Tech.

This quarter’s successful placements include:

Function Focus area Location
CEO Microbiome-based therapeutics US
CEO CNS diseases Singapore
Chief Medical Officer Autoimmune disorders Italy
Chief Scientific Officer Immuno-oncology UK
Chief Medical Officer Analgesics/Pain solutions US
Chief Technical Officer Synthetic bio & metabolic engineering Denmark
VP Clinical Operations Vaccines Denmark
VP Marketing Drug delivery Ireland
VP Sales Drug delivery systems Germany
VP People Oncology US
Head of Global Clinical Affairs Vascular stent technology UK
Head of Data & Analytics Antibody therapeutics UK
Laboratory Director Veterinary services UK
Quality & Regulatory Affairs Director A.I. enabled diagnostics US
Board Director Oncology Singapore
Digital Board Director Fertility services Denmark
Senior US Venture Partner Life science VC UK

Newly opened projects include:

Function Focus area Location
CEO RNA epigenetics Belgium
President US Immuno-oncology China
Chief Commercial Officer Point of care diagnostics Belgium
Chief Operating Officer Rare diseases China
Chief Medical Officer Regenerative medicine US
Chief Technical Officer Life science tools Germany
Chief Financial Officer Precision cancer therapeutics US
Head of Sales Pharmaceutical logistics & supply chain Sweden
VP Sales & Marketing Neurostimulation devices Finland
VP General Manager Pharma Services Molecular diagnostics US
R&D team build mRNA immunotherapies UK
Partner Transatlantic life sciences investor UK


A new version of Coulter Partners is available.